<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
	<title>pubmed: "wellik dm"</title>
	<link>https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Wellik%20DM%22%5BAuthor%5D</link>
	<description>NCBI: db=pubmed; Term="Wellik DM"[Author]</description>
	<language>en-us</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<ttl>1440</ttl>
	<image>
		<title>NCBI pubmed</title>
		<url>https://www.ncbi.nlm.nih.gov/entrez/query/static/gifs/iconsml.gif</url>
		<link>https://www.ncbi.nlm.nih.gov/sites/entrez</link>
		<description>PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.</description>
	</image>
<item>
    <title>Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/32598229?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"/><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=32598229">Related Articles</a></td></tr></table>
        <p><b>Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.</b></p>          
        <p>Tissue Eng Part A. 2020 07;26(13-14):747-758</p>
        <p>Authors:  Fogg KC, Renner CM, Christian H, Walker A, Marty-Santos L, Khan A, Olson WR, Parent C, O'Shea A, Wellik DM, Weisman PS, Kreeger PK</p>
        <p>Abstract<br/>
        It is well known that during ovarian cancer progression, the omentum transforms from a thin lacy organ to a thick tougher tissue. However, the mechanisms regulating this transformation and the implications of the altered microenvironment on ovarian cancer progression remain unclear. To address these questions, the global and local concentrations of collagen I were determined for normal and metastatic human omentum. Collagen I was increased 5.3-fold in omenta from ovarian cancer patients and localized to areas of activated fibroblasts rather than regions with a high density of cancer cells. Transforming growth factor beta 1 (TGFβ1) was detected in ascites from ovarian cancer patients (4 ng/mL), suggesting a potential role for TGFβ1 in the observed increase in collagen. Treatment with TGFβ1 induced fibroblast activation, proliferation, and collagen deposition in mouse omental explants and an in vitro model with human omental fibroblasts. Finally, the impact of increased collagen I on ovarian cancer cells was determined by examining proliferation on collagen I gels formulated to mimic normal and cancerous omenta. While collagen density alone had no impact on proliferation, a synergistic effect was observed with collagen density and heparin-binding epidermal growth factor treatment. These results suggest that TGFβ1 induces collagen deposition from the resident fibroblasts in the omentum and that this altered microenvironment impacts cancer cell response to growth factors found in ascites. Impact statement Using quantitative analysis of patient samples, in vitro models of the metastatic ovarian cancer microenvironment were designed with pathologically relevant collagen densities and growth factor concentrations. Studies in these models support a mechanism where transforming growth factor β1 in the ascites fluid induces omental fibroblast proliferation, activation, and deposition of collagen I, which then impacts tumor cell proliferation in response to additional ascites growth factors such as heparin-binding epidermal growth factor. This approach can be used to dissect mechanisms involved in microenvironmental modeling in multiple disease applications.<br/>
        </p><p>PMID: 32598229 [PubMed - in process]</p>
    ]]></description>
    <author> Fogg KC, Renner CM, Christian H, Walker A, Marty-Santos L, Khan A, Olson WR, Parent C, O'Shea A, Wellik DM, Weisman PS, Kreeger PK</author>
    <category>Tissue Eng Part A</category>
    <guid isPermaLink="false">PubMed:32598229</guid>
</item>
<item>
    <title>Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/32454112?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="https://linkinghub.elsevier.com/retrieve/pii/S2352-345X(20)30074-6"><img alt="Icon for Elsevier Science" title="Read full text in Elsevier Science" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-elsevieroa.png" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32454112/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=32454112">Related Articles</a></td></tr></table>
        <p><b>Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma.</b></p>          
        <p>Cell Mol Gastroenterol Hepatol. 2020;10(3):581-599</p>
        <p>Authors:  Garcia PE, Adoumie M, Kim EC, Zhang Y, Scales MK, El-Tawil YS, Shaikh AZ, Wen HJ, Bednar F, Allen BL, Wellik DM, Crawford HC, Pasca di Magliano M</p>
        <p>Abstract<br/>
        BACKGROUND &amp; AIMS: Although the healthy pancreas consists mostly of epithelial cells, pancreatic cancer and the precursor lesions known as pancreatic intraepithelial neoplasia, are characterized by an extensive accumulation of fibroinflammatory stroma that includes a substantial and heterogeneous fibroblast population. The cellular origin of fibroblasts within the stroma has not been determined. Here, we show that the Gli1 and Hoxb6 markers label distinct fibroblast populations in the healthy mouse pancreas. We then set out to determine whether these distinct fibroblast populations expanded during carcinogenesis.<br/>
        METHODS: We developed genetically engineered models using a dual-recombinase approach that allowed us to induce pancreatic cancer formation through codon-optimized Flp recombinase-driven epithelial recombination of Kirsten rat sarcoma viral oncogene homolog while labeling Gli1+ or Hoxb6+ fibroblasts in an inducible manner. By using these models, we lineage-traced these 2 fibroblast populations during the process of carcinogenesis.<br/>
        RESULTS: Although in the healthy pancreas Gli1+ fibroblasts and Hoxb6+ fibroblasts are present in similar numbers, they contribute differently to the stroma in carcinogenesis. Namely, Gli1+ fibroblasts expand dramatically, whereas Hoxb6+ cells do not.<br/>
        CONCLUSIONS: Fibroblasts present in the healthy pancreas expand during carcinogenesis, but with a different prevalence for different subtypes. Here, we compared Gli1+ and Hoxb6+ fibroblasts and found only Gli1+ expanded to contribute to the stroma during pancreatic carcinogenesis.<br/>
        </p><p>PMID: 32454112 [PubMed - in process]</p>
    ]]></description>
    <author> Garcia PE, Adoumie M, Kim EC, Zhang Y, Scales MK, El-Tawil YS, Shaikh AZ, Wen HJ, Bednar F, Allen BL, Wellik DM, Crawford HC, Pasca di Magliano M</author>
    <category>Cell Mol Gastroenterol Hepatol</category>
    <guid isPermaLink="false">PubMed:32454112</guid>
</item>
<item>
    <title>Hox genes maintain critical roles in the adult skeleton.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/32170021?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.pnas.org/cgi/pmidlookup?view=long&amp;pmid=32170021"><img alt="Icon for HighWire" title="Read full text in HighWire" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-custom-pnas_full_free.gif" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32170021/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=32170021">Related Articles</a></td></tr></table>
        <p><b>Hox genes maintain critical roles in the adult skeleton.</b></p>          
        <p>Proc Natl Acad Sci U S A. 2020 03 31;117(13):7296-7304</p>
        <p>Authors:  Song JY, Pineault KM, Dones JM, Raines RT, Wellik DM</p>
        <p>Abstract<br/>
        Hox genes are indispensable for the proper patterning of the skeletal morphology of the axial and appendicular skeleton during embryonic development. Recently, it has been demonstrated that Hox expression continues from embryonic stages through postnatal and adult stages exclusively in a skeletal stem cell population. However, whether Hox genes continue to function after development has not been rigorously investigated. We generated a Hoxd11 conditional allele and induced genetic deletion at adult stages to show that Hox11 genes play critical roles in skeletal homeostasis of the forelimb zeugopod (radius and ulna). Conditional loss of Hox11 function at adult stages leads to replacement of normal lamellar bone with an abnormal woven bone-like matrix of highly disorganized collagen fibers. Examining the lineage from the Hox-expressing mutant cells demonstrates no loss of stem cell population. Differentiation in the osteoblast lineage initiates with Runx2 expression, which is observed similarly in mutants and controls. With loss of Hox11 function, however, osteoblasts fail to mature, with no progression to osteopontin or osteocalcin expression. Osteocyte-like cells become embedded within the abnormal bony matrix, but they completely lack dendrites, as well as the characteristic lacuno-canalicular network, and do not express SOST. Together, our studies show that Hox11 genes continuously function in the adult skeleton in a region-specific manner by regulating differentiation of Hox-expressing skeletal stem cells into the osteolineage.<br/>
        </p><p>PMID: 32170021 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Song JY, Pineault KM, Dones JM, Raines RT, Wellik DM</author>
    <category>Proc Natl Acad Sci U S A</category>
    <guid isPermaLink="false">PubMed:32170021</guid>
</item>
<item>
    <title>Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/31667107?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="https://linkinghub.elsevier.com/retrieve/pii/S2215-0161(19)30224-9"><img alt="Icon for Elsevier Science" title="Read full text in Elsevier Science" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-elsevieroa.png" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31667107/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=31667107">Related Articles</a></td></tr></table>
        <p><b>Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse.</b></p>          
        <p>MethodsX. 2019;6:2088-2100</p>
        <p>Authors:  Pineault KM, Novoa A, Lozovska A, Wellik DM, Mallo M</p>
        <p>Abstract<br/>
        Genetically modified model organisms are valuable tools for probing gene function, dissecting complex signaling networks, studying human disease, and more. CRISPR/Cas9 technology has significantly democratized and reduced the time and cost of generating genetically modified models to the point that small gene edits are now routinely and efficiently generated in as little as two months. However, generation of larger and more sophisticated gene-modifications continues to be inefficient. Alternative ways to provide the replacement DNA sequence, method of Cas9 delivery, and tethering the template sequence to Cas9 or the guide RNA (gRNA) have all been tested in an effort to maximize homology-directed repair for precise modification of the genome. We present two CRISPR/Cas9 methods that have been used to successfully generate large and complex gene-edits in mouse. In the first method, the Cas9 enzyme is used in conjunction with two sgRNAs and a long single-stranded DNA (lssDNA) template prepared by an alternative protocol. The second method utilizes a tethering approach to couple a biotinylated, double-stranded DNA (dsDNA) template to a Cas9-streptavidin fusion protein. •Alternative method for generating long, single-stranded DNA templates for CRISPR/Cas9 editing.•Demonstration that using two sgRNAs with Cas9-streptavidin/biotinylated-dsDNA is feasible for large DNA modifications.<br/>
        </p><p>PMID: 31667107 [PubMed]</p>
    ]]></description>
    <author> Pineault KM, Novoa A, Lozovska A, Wellik DM, Mallo M</author>
    <category>MethodsX</category>
    <guid isPermaLink="false">PubMed:31667107</guid>
</item>
<item>
    <title>Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes throughout life.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/31320650?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://dx.doi.org/10.1038/s41467-019-11100-4"><img alt="Icon for Nature Publishing Group" title="Read full text in Nature Publishing Group" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.nature.com-images-lo_npg.gif" border="0"/></a> <a href="https://doi.org/10.1038/s41467-019-11100-4"><img alt="Icon for Nature Publishing Group" title="Read full text in Nature Publishing Group" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.nature.com-images-npg_logo.gif" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31320650/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=31320650">Related Articles</a></td></tr></table>
        <p><b>Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes throughout life.</b></p>          
        <p>Nat Commun. 2019 07 18;10(1):3168</p>
        <p>Authors:  Pineault KM, Song JY, Kozloff KM, Lucas D, Wellik DM</p>
        <p>Abstract<br/>
        Multipotent mesenchymal stromal cells (MSCs) are required for skeletal formation, maintenance, and repair throughout life; however, current models posit that postnatally arising long-lived adult MSCs replace transient embryonic progenitor populations. We previously reported exclusive expression and function of the embryonic patterning transcription factor, Hoxa11, in adult skeletal progenitor-enriched MSCs. Here, using a newly generated Hoxa11-CreERT2 lineage-tracing system, we show Hoxa11-lineage marked cells give rise to all skeletal lineages throughout the life of the animal and persist as MSCs. Hoxa11 lineage-positive cells give rise to previously described progenitor-enriched MSC populations marked by LepR-Cre and Osx-CreER, placing them upstream of these populations. Our studies establish that Hox-expressing cells are skeletal stem cells that arise from the earliest stages of skeletal development and self-renew throughout the life of the animal.<br/>
        </p><p>PMID: 31320650 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Pineault KM, Song JY, Kozloff KM, Lucas D, Wellik DM</author>
    <category>Nat Commun</category>
    <guid isPermaLink="false">PubMed:31320650</guid>
</item>
<item>
    <title>Bone morphology is regulated modularly by global and regional genetic programs.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/31221640?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://dev.biologists.org/cgi/pmidlookup?view=long&amp;pmid=31221640"><img alt="Icon for HighWire" title="Read full text in HighWire" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-standard-develop_final_free.gif" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31221640/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=31221640">Related Articles</a></td></tr></table>
        <p><b>Bone morphology is regulated modularly by global and regional genetic programs.</b></p>          
        <p>Development. 2019 07 26;146(14):</p>
        <p>Authors:  Eyal S, Kult S, Rubin S, Krief S, Felsenthal N, Pineault KM, Leshkowitz D, Salame TM, Addadi Y, Wellik DM, Zelzer E</p>
        <p>Abstract<br/>
        Bone protrusions provide stable anchoring sites for ligaments and tendons and define the unique morphology of each long bone. Despite their importance, the mechanism by which superstructures are patterned is unknown. Here, we identify components of the genetic program that control the patterning of Sox9 +/Scx + superstructure progenitors in mouse and show that this program includes both global and regional regulatory modules. Using light-sheet fluorescence microscopy combined with genetic lineage labeling, we mapped the broad contribution of the Sox9 +/Scx + progenitors to the formation of bone superstructures. Then, by combining literature-based evidence, comparative transcriptomic analysis and genetic mouse models, we identified Gli3 as a global regulator of superstructure patterning, whereas Pbx1, Pbx2, Hoxa11 and Hoxd11 act as proximal and distal regulators, respectively. Moreover, by demonstrating a dose-dependent pattern regulation in Gli3 and Pbx1 compound mutations, we show that the global and regional regulatory modules work in a coordinated manner. Collectively, our results provide strong evidence for genetic regulation of superstructure patterning, which further supports the notion that long bone development is a modular process.This article has an associated 'The people behind the papers' interview.<br/>
        </p><p>PMID: 31221640 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Eyal S, Kult S, Rubin S, Krief S, Felsenthal N, Pineault KM, Leshkowitz D, Salame TM, Addadi Y, Wellik DM, Zelzer E</author>
    <category>Development</category>
    <guid isPermaLink="false">PubMed:31221640</guid>
</item>
<item>
    <title>Anatomic Origin of Osteochondrogenic Progenitors Impacts Sensitivity to EWS-FLI1-Induced Transformation.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/30845695?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30845695/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=30845695">Related Articles</a></td></tr></table>
        <p><b>Anatomic Origin of Osteochondrogenic Progenitors Impacts Sensitivity to EWS-FLI1-Induced Transformation.</b></p>          
        <p>Cancers (Basel). 2019 Mar 06;11(3):</p>
        <p>Authors:  Pfaltzgraff ER, Apfelbaum A, Kassa AP, Song JY, Jiang W, Suhan TK, Wellik DM, Lawlor ER</p>
        <p>Abstract<br/>
        Ewing sarcomas predominantly arise in pelvic and stylopod bones (i.e., femur and humerus), likely as a consequence of EWS-FLI1 oncogene-induced transformation of mesenchymal stem/progenitor cells (MSCs). MSCs located in the embryonic superficial zone cells (eSZ) of limbs express anatomically distinct posterior Hox genes. Significantly, high expression of posterior HOXD genes, especially HOXD13, is a hallmark of Ewing sarcoma. These data drove our hypothesis that Hox genes in posterior skeleton MSCs contribute to Ewing sarcoma tumorigenesis. We isolated eSZ cells from stylopod and zeugopod (i.e., tibia/fibula, radius/ulna) bones, from wild-type and Hoxd13 mutant embryos, and tested the impact of EWS-FLI1 transduction on cell proliferation, gene expression, and tumorigenicity. Our data demonstrate that both stylopod and zeugopod eSZ cells tolerate EWS-FLI1 but that stylopod eSZ cells are relatively more susceptible, demonstrating changes in proliferation and gene expression consistent with initiation of malignant transformation. Significantly, loss of Hoxd13 had no impact, showing that it is dispensable for the initiation of EWS-FLI1-induced transformation in mouse MSCs. These findings show that MSCs from anatomically distinct sites are differentially susceptible to EWS-FLI1-induced transformation, supporting the premise that the dominant presentation of Ewing sarcoma in pelvic and stylopod bones is attributable to anatomically-defined differences in MSCs.<br/>
        </p><p>PMID: 30845695 [PubMed]</p>
    ]]></description>
    <author> Pfaltzgraff ER, Apfelbaum A, Kassa AP, Song JY, Jiang W, Suhan TK, Wellik DM, Lawlor ER</author>
    <category>Cancers (Basel)</category>
    <guid isPermaLink="false">PubMed:30845695</guid>
</item>
<item>
    <title>Development, repair, and regeneration of the limb musculoskeletal system.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/30797517?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="https://linkinghub.elsevier.com/retrieve/pii/S0070-2153(18)30111-X"><img alt="Icon for Elsevier Science" title="Read full text in Elsevier Science" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=30797517">Related Articles</a></td></tr></table>
        <p><b>Development, repair, and regeneration of the limb musculoskeletal system.</b></p>          
        <p>Curr Top Dev Biol. 2019;132:451-486</p>
        <p>Authors:  Song JY, Pineault KM, Wellik DM</p>
        <p>Abstract<br/>
        The limb musculoskeletal system provides a primary means for locomotion, manipulation of objects and protection for most vertebrate organisms. Intricate integration of the bone, tendon and muscle tissues are required for function. These three tissues arise largely independent of one another, but the connections formed during later development are maintained throughout life and are re-established following injury. Each of these tissues also have mesenchymal stem/progenitor cells that function in maintenance and repair. Here in, we will review the major events in the development of limb skeleton, tendon, and muscle tissues, their response to injury, and discuss current knowledge regarding resident progenitor/stem cells within each tissue that participate in development, repair, and regeneration in vivo.<br/>
        </p><p>PMID: 30797517 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Song JY, Pineault KM, Wellik DM</author>
    <category>Curr Top Dev Biol</category>
    <guid isPermaLink="false">PubMed:30797517</guid>
</item>
<item>
    <title>Hox5 genes direct elastin network formation during alveologenesis by regulating myofibroblast adhesion.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/30348760?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.pnas.org/cgi/pmidlookup?view=long&amp;pmid=30348760"><img alt="Icon for HighWire" title="Read full text in HighWire" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-custom-pnas_full_free.gif" border="0"/></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30348760/"><img alt="Icon for PubMed Central" title="Read full text in PubMed Central" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-pubmed-pmc.png" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=30348760">Related Articles</a></td></tr></table>
        <p><b>Hox5 genes direct elastin network formation during alveologenesis by regulating myofibroblast adhesion.</b></p>          
        <p>Proc Natl Acad Sci U S A. 2018 11 06;115(45):E10605-E10614</p>
        <p>Authors:  Hrycaj SM, Marty-Santos L, Cebrian C, Rasky AJ, Ptaschinski C, Lukacs NW, Wellik DM</p>
        <p>Abstract<br/>
        Hox5 genes (Hoxa5, Hoxb5, Hoxc5) are exclusively expressed in the lung mesenchyme during embryogenesis, and the most severe phenotypes result from constitutive loss of function of all three genes. Because Hox5 triple null mutants exhibit perinatal lethality, the contribution of this paralogous group to postembryonic lung development is unknown. Intriguingly, expression of all three Hox5 genes peaks during the first 2 weeks after birth, reaching levels far exceeding those measured at embryonic stages, and surviving Hoxa5 single and Hox5 AabbCc compound mutants exhibit defects in the localization of alveolar myofibroblasts. To define the contribution of the entire Hox5 paralogous group to this process, we generated an Hoxa5 conditional allele to use with our existing null alleles for Hoxb5 and Hoxc5 Postnatally, mesenchymal deletion of Hoxa5 in an Hoxb5/Hoxc5 double-mutant background results in severe alveolar simplification. The elastin network required for alveolar formation is dramatically disrupted in Hox5 triple mutants, while the basal lamina, interstitial matrix, and fibronectin are normal. Alveolar myofibroblasts remain Pdgfrα+/SMA+ double positive and present in normal numbers, indicating that the irregular elastin network is not due to fibroblast differentiation defects. Rather, we observe that SMA+ myofibroblasts of Hox5 triple mutants are morphologically abnormal both in vivo and in vitro with highly reduced adherence to fibronectin. This loss of adhesion is a result of loss of the integrin heterodimer Itga5b1 in mutant fibroblasts. Collectively, these data show an important role for Hox5 genes in lung fibroblast adhesion necessary for proper elastin network formation during alveologenesis.<br/>
        </p><p>PMID: 30348760 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Hrycaj SM, Marty-Santos L, Cebrian C, Rasky AJ, Ptaschinski C, Lukacs NW, Wellik DM</author>
    <category>Proc Natl Acad Sci U S A</category>
    <guid isPermaLink="false">PubMed:30348760</guid>
</item>
<item>
    <title>Loss of Hox5 function results in myofibroblast mislocalization and distal lung matrix defects during postnatal development.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/29752580?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="https://dx.doi.org/10.1007/s11427-017-9290-1"><img alt="Icon for Springer" title="Read full text in Springer" src="//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--production.springer.de-OnlineResources-Logos-springerlink.gif" border="0"/></a> </td><td align="right"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Link&amp;LinkName=pubmed_pubmed&amp;from_uid=29752580">Related Articles</a></td></tr></table>
        <p><b>Loss of Hox5 function results in myofibroblast mislocalization and distal lung matrix defects during postnatal development.</b></p>          
        <p>Sci China Life Sci. 2018 Sep;61(9):1030-1038</p>
        <p>Authors:  Hrycaj SM, Marty-Santos L, Rasky AJ, Lukacs NW, Wellik DM</p>
        <p>Abstract<br/>
        Alveologenesis is the final stage of lung development and is responsible for the formation of the principle gas exchange units called alveoli. The lung mesenchyme, in particular the alveolar myofibroblasts, are drivers of alveolar development, however, few key regulators that govern the proper distribution and behavior of these cells in the distal lung during alveologenesis have been identified. While Hox5 triple mutants (Hox5 aabbcc) exhibit neonatal lethality, four-allele, compound mutant mice (Hox5 AabbCc) are born in Mendelian ratios and are phenotypically normal at birth. However, they exhibit defects in alveologenesis characterized by a BPD-like phenotype by early postnatal stages that becomes more pronounced at adult stages. Invasive pulmonary functional analyses demonstrate significant increases in total lung volume and compliance and a decrease in elastance in Hox5 compound mutants. SMA+ myofibroblasts in the distal lung are distributed abnormally during peak stages of alveologenesis and aggregate, resulting in the formation of a disrupted elastin network. Examination of other key components of the distal lung ECM, as well as other epithelial cells and lipofibroblasts reveal no differences in distribution. Collectively, these data indicate that Hox5 genes play a critical role in alveolar development by governing the proper cellular behavior of myofibroblasts during alveologenesis.<br/>
        </p><p>PMID: 29752580 [PubMed - indexed for MEDLINE]</p>
    ]]></description>
    <author> Hrycaj SM, Marty-Santos L, Rasky AJ, Lukacs NW, Wellik DM</author>
    <category>Sci China Life Sci</category>
    <guid isPermaLink="false">PubMed:29752580</guid>
</item>
</channel>
</rss>
